Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Biorientation of chromosomes in cell division protein 1-like 2 (BOD1L2) is a protein-coding gene predicted to be involved in cell division, specifically in chromosome biorientation, likely through the detection or correction of erroneous kinetochore-microtubule attachments during mitosis. It is predicted to localize to the centrosome, cytoplasm, and kinetochore. BOD1L2 is related to BOD1, which is known to participate in mitotic chromosome biorientation. BOD1L2 has no well-documented role as a therapeutic target, disease association, or drug interaction at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Biorientation of chromosomes in cell division protein 1-like 2 (BOD1L2).